TariffCheck
All articles

How to Save Money on Prescription Drugs Before the 2026 Tariff (10 Strategies)

The 100% pharmaceutical tariff hits July 31, 2026. Here are 10 proven strategies — from generic substitution to manufacturer coupons — to keep your medication costs manageable.

The 100% tariff on imported brand-name pharmaceuticals takes effect July 31, 2026 (or September 29 for non-Annex III companies). If your medication is imported and not exempt, you could see monthly costs rise 30-100%. This guide walks through 10 concrete strategies — in order of expected savings — to protect your medication budget.

Your Strategy Stack

Strategy Potential Monthly Savings Difficulty
Switch to a generic $50-$800+ Easy
Switch to a biosimilar $100-$2,000+ Easy-Medium
Switch to a US-made brand alternative $100-$1,000+ Medium
Apply for manufacturer patient assistance $100-$1,500+ Medium
Use manufacturer copay cards $50-$200 Easy
Compare cash prices (GoodRx, Mark Cuban Cost Plus) $30-$300+ Easy
Request 90-day supply Save 10-20% per pill Easy
Appeal formulary tier placement $25-$200 Medium
Mail-order pharmacy 10-25% vs retail Easy
Free clinic / community health program Can be free Varies

Strategy 1: Switch to a Generic

Generics are explicitly exempt from the tariff. If your brand drug has a generic equivalent, switching is almost always the cheapest option.

Brand (may be affected) Generic (exempt) Typical Cash Savings
Lipitor atorvastatin $300/mo → $5/mo
Crestor rosuvastatin $250/mo → $10/mo
Synthroid levothyroxine $50/mo → $10/mo
Nexium esomeprazole $200/mo → $12/mo
Januvia (generic May 2026) sitagliptin $575/mo → projected $50-100/mo
Cialis tadalafil $250/mo → $15/mo
Lexapro escitalopram $100/mo → $8/mo
Zocor simvastatin $80/mo → $5/mo
Advair Diskus fluticasone/salmeterol (Wixela Inhub) $400/mo → $100-150/mo
Symbicort budesonide/formoterol generic $380/mo → $100-150/mo

How to switch: Most state pharmacy laws allow automatic generic substitution. Ask your pharmacist. If your prescription says "DAW" (Dispense As Written), ask your doctor for a new prescription without that notation.

Strategy 2: Switch to a Biosimilar

Biosimilars are FDA-approved near-copies of biologic drugs. They're explicitly exempt from the tariff.

Reference Biologic Biosimilars Available Typical Savings
Humira (adalimumab) Amjevita, Cyltezo, Hyrimoz, Yuflyma, + 5 more 20-60% off Humira price
Enbrel (etanercept) Erelzi, Eticovo 10-40% off Enbrel
Remicade (infliximab) Inflectra, Renflexis, Avsola 30-50% off Remicade
Neupogen Zarxio, Nivestym, Releuko 30-50% off
Lantus (insulin glargine) Semglee, Rezvoglar 30-65% off Lantus
Herceptin (trastuzumab) Multiple 20-40% off Herceptin

Note: Humira and Enbrel are themselves exempt (US-made), but biosimilars are still often cheaper. For Lantus (imported from France, affected by tariff), biosimilars like Semglee become critical after July 31.

Strategy 3: Switch to a US-Made Brand Alternative

When no generic/biosimilar exists, a US-made brand alternative is exempt from the tariff.

If You're Taking Consider Instead Why
Ozempic (Denmark) Mounjaro (USA) Same class, exempt from tariff
Wegovy (Denmark) Zepbound (USA) Same class, exempt from tariff
Jardiance (Germany) Steglatro (USA) Same class, exempt from tariff
Farxiga (Sweden) Steglatro (USA) Same class, exempt from tariff
Lantus (France) Humalog U-500 (USA) or NPH US insulins for basal coverage
Rinvoq (Germany) Xeljanz (USA) JAK inhibitor class alternative
Brilinta (Sweden) Effient / Brilinta's generic alternative Antiplatelet alternatives

Clinical considerations apply — talk to your doctor.

Strategy 4: Apply for Manufacturer Patient Assistance Programs

Every major pharma company runs patient assistance programs (PAPs) that provide drugs free or steeply discounted for eligible patients.

Major Programs

Company Program Name Typical Qualification
Novo Nordisk NovoCare / Novo Nordisk Patient Assistance Program Income up to 400% FPL; no/limited insurance
Merck Merck Helps Income-based; uninsured or under-insured
Pfizer Pfizer RxPathways Income-based; specific drugs
Eli Lilly Lilly Cares Income-based
AbbVie AbbVie Patient Assistance Foundation Income up to 600% FPL for specialty drugs
BMS BMS Access Support Income-based
J&J Johnson & Johnson Patient Assistance Foundation Income-based
AstraZeneca AZ&Me Income up to 300% FPL

What You Need to Apply

  • Income verification (tax return, pay stubs)
  • Proof of US residency
  • Physician enrollment (your doctor's office helps)
  • Insurance documentation (including denial letters if applicable)

Applications take 2-6 weeks. Start now if you think you may need assistance after July 31.

Strategy 5: Use Manufacturer Copay Cards

Copay cards are different from PAPs — they're for commercially insured patients. They bring your copay down to as low as $0-25/month.

Drug Copay Card Maximum Benefit
Ozempic Novo Nordisk Savings Card Up to $150/month
Jardiance Jardiance Savings Card As low as $10/month
Eliquis Eliquis CoPay Card $10/month
Rinvoq Rinvoq Complete Savings Card $5/month
Skyrizi Skyrizi Complete Savings $5/month
Stelara Stelara withMe Savings Varies
Humira Humira Complete Savings Card $5/month
Dupixent Dupixent MyWay Up to $13,000/year total benefit

Critical: Copay cards are not allowed for Medicare or Medicaid patients under federal anti-kickback law. They're for commercial insurance only.

Strategy 6: Compare Cash Prices

Several services offer discounted cash prices that often beat insurance copays:

GoodRx

  • Shows prices across pharmacies for your specific medication and ZIP code
  • Can be lower than insurance copay
  • No insurance required
  • Cannot be combined with insurance at checkout

Mark Cuban Cost Plus Drugs (costplusdrugs.com)

  • Transparent pricing: drug cost + 15% markup + $3 dispensing fee
  • Mail-order only
  • Growing generic catalog; selective on brand drugs
  • Example: Imatinib 400mg (generic Gleevec): $14.40/mo vs $10,000+ brand

Amazon Pharmacy

  • Prime members get discounts
  • Transparent pricing
  • Delivery

Costco Pharmacy

  • Membership not required for pharmacy
  • Often cheaper than chain pharmacies for generics
  • No insurance needed

Strategy 7: Request a 90-Day Supply

Most maintenance medications can be filled as 90-day supplies with doctor approval. Benefits:

  • Lower per-pill cost (usually 10-20% savings)
  • Fewer trips to the pharmacy
  • Lock in pre-tariff pricing for 90 days if timed correctly

Tariff-specific tactic: If you can get a 90-day fill in mid-July 2026, you lock in pre-tariff pricing through mid-October. Check with your insurance about 90-day supply eligibility and refill timing.

Strategy 8: Appeal Your Formulary Tier Placement

If the tariff causes your drug to move to a higher formulary tier (higher copay), you can appeal.

When to Appeal

  • Your drug moved from Tier 2 to Tier 3 ($45 → $80 copay)
  • Prior authorization was added
  • Step therapy requirement was added (must try cheaper drug first)

How to Appeal

  1. Request exception from your insurance
  2. Provide medical justification — your doctor documents why this specific drug is medically necessary
  3. Cite clinical evidence — studies, guidelines, treatment failure history
  4. Appeal denial — most plans have multiple appeal levels

Success rates are reasonable if the medical justification is strong. Your doctor's office often handles the paperwork.

Strategy 9: Use Mail-Order Pharmacy

Mail-order pharmacies (through your insurance) typically charge 10-25% less per pill than retail:

  • Express Scripts
  • CVS Caremark Mail Service
  • OptumRx Home Delivery
  • Kaiser Permanente Mail Order

Switch to mail-order for maintenance medications to capture ongoing savings.

Strategy 10: Free Clinics and Community Programs

For uninsured or underinsured patients, community resources can bridge gaps:

  • Federally Qualified Health Centers (FQHCs) — sliding-scale pricing, often dispense at cost
  • 340B hospitals — hospitals that serve low-income populations get discounted drugs under federal law
  • State pharmaceutical assistance programs — most states have programs for seniors (e.g., PACE in Pennsylvania, EPIC in New York)
  • NeedyMeds.org — aggregator of patient assistance resources
  • RxAssist.org — searchable database of PAPs

Putting It All Together: An Example

Scenario: Uninsured patient taking Ozempic for diabetes, currently paying $968/month cash.

Strategy stack:

  1. Apply to NovoCare Patient Assistance Program (most effective — may get Ozempic free if income-qualified)
  2. If income-qualified: done, free. If not:
  3. Talk to doctor about switching to Mounjaro (US-made, exempt from tariff) — ~$1,069 cash today but won't rise with tariff
  4. Apply for Lilly Cares program for Mounjaro
  5. Use Mounjaro manufacturer copay card (for commercial insurance) or Lilly's cash savings card
  6. Request 90-day supply for additional savings
  7. Use Costco Pharmacy or Mark Cuban Cost Plus Drugs for cash pricing

Likely outcome: From $968/month uninsured → $0-25/month with PAP qualification, or ~$400-500/month cash with Mounjaro switch + 90-day supply.

Frequently Asked Questions

Which strategy should I try first?

Always start with the easiest: check if a generic exists. 80%+ of patients find their drug has a generic or near-generic equivalent. Talk to your pharmacist first — they'll know immediately.

Can I combine multiple strategies?

Yes, with caveats. PAPs typically require you to be uninsured or have insufficient insurance. Copay cards require commercial insurance. GoodRx can't be combined with insurance at the register. Ask at each point: "Can I also use..."

What if my insurance denies my appeal?

Escalate to external review. All commercial insurance plans are required to offer external review by an independent medical reviewer. This is often where strong clinical cases succeed.

How long do PAP applications take?

Typically 2-6 weeks. Start now if you think you may need assistance. Some programs offer emergency fills (30-day supply) while the application processes.

Will insurance premiums go up because of the tariff?

Likely yes, modestly. Insurance companies will pass a portion of increased drug costs through to premiums. Expect 3-8% premium increases in 2026-2027 plan years as tariff impacts flow through.

Conclusion

The 2026 pharmaceutical tariff is real, but you have options. Start with generic substitution, add biosimilar and US-made alternatives, layer in manufacturer programs, and use cash-price comparison for uninsured gaps. For most patients, stacking 2-3 strategies reduces the tariff impact to near zero. Check your specific drug's tariff status and exemption options here.

Try TariffCheck Free

Calculate import duties, Section 301 tariffs, and total landed cost in seconds

Calculate Tariff Free →